On September 27, 2024, the Food and Drug Administration conferred traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and pediatric patients aged 2 years and older diagn...
ret-inhibitors
Medullary Thyroid Cancer Treatment
Medullary thyroid cancer (MTC) is an aggressive but rare type of thyroid cancer that develops from the parafollicular C cells of the thyroid gland. In contrast to o...
ret-inhibitors